Oniria Therapeutics

Description: Oniria Therapeutics develops first-in-class precision oncology drugs by targeting cell dormancy to combat persistent cancer.

Country: Spain

Based in: Barcelona

Founded: 2021

Funding Stage: Pre-Seed

Tags: ['biotechnology', 'cancer', 'cell dormancy', 'biopharma']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.